14-day Premium Trial Subscription Try For FreeTry Free

Contrasting Outlook Therapeutics (NASDAQ:OTLK) and Bio-Techne (NASDAQ:TECH)

08:32am, Friday, 26'th Nov 2021 Dakota Financial News
Outlook Therapeutics (NASDAQ:OTLK) and Bio-Techne (NASDAQ:TECH) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, valuation, profitability and analyst recommendations. Valuation and Earnings This table compares Outlook Therapeutics and Bio-Technes revenue, earnings per share (EPS) and valuation. []

Analysts Set Bio-Techne Co. (NASDAQ:TECH) Price Target at $476.00

07:16pm, Thursday, 25'th Nov 2021 Dakota Financial News
Bio-Techne Co. (NASDAQ:TECH) has been assigned a consensus rating of Buy from the nine analysts that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among brokers that have covered []

Kim Kelderman Sells 500 Shares of Bio-Techne Co. (NASDAQ:TECH) Stock

11:12am, Thursday, 25'th Nov 2021 Dakota Financial News
Bio-Techne Co. (NASDAQ:TECH) insider Kim Kelderman sold 500 shares of the company’s stock in a transaction that occurred on Friday, November 19th. The shares were sold at an average price of $505.38, for a total value of $252,690.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed […]
MINNEAPOLIS, Nov. 22, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at two upcoming investor conferences. Chuck Kummeth, President and Chief Executive
Baron funds took big stakes in Nvidia, Sea, Shopify and other companies in the third quarter.

Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

11:20am, Wednesday, 17'th Nov 2021 Zacks Investment Research
Smart Beta ETF report for PBE
Tissue Microarray (TMA) refers to the innovative practice of relocating multiple tissues sections from conventional histologic paraffin blocks so that the tissues from multiple samples can be observed on the same slide.It is a novel and useful tool to efficiently
Techne (TECH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
REGN vs. TECH: Which Stock Is the Better Value Option?
Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q1 2022 Results - Earnings Call Transcript

Bio-Techne's Earnings: A Preview

11:03am, Monday, 01'st Nov 2021
Bio-Techne (NASDAQ:TECH) is set to give its latest quarterly earnings report on Tuesday, 2021-11-02. Here's what investors need to know before the announcement.
In GuruFocus' High Quality Low CAPEX model portfolio, the companies with the biggest year-to-date returns are Fortinet Inc. ( FTNT , Financial), Nvidia Corp. ( NVDA , Financial), Old Dominion Freight
MINNEAPOLIS, Oct. 11, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, November 2, 2021, at 8:00 a.m. CDT
REGN vs. TECH: Which Stock Is the Better Value Option?
Piper Sandler chief market technician Craig Johnson shares some of his firm's best investing ideas for the rest of the year, including some under-the-radar names in the chemical and energy sectors.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE